Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: VYEPTI — Original Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

FDA approved VYEPTI (eptinezumab-jjmr) under an original Biologics License Application for the preventive treatment of chronic migraine in adults. This marks th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VYEPTI (eptinezumab)

Snippet

ORIG AP for VYEPTI (EPTINEZUMAB-JJMR)